Day: February 5, 2026

Rio Silver Highlights Underexplored Silver-Gold Potential at Maria Norte Within a Proven Peruvian Mining District

Written by Customer Service on February 5, 2026. Posted in Public Companies.

Structural Continuity and Underexplored Vein Systems Highlight Potential Scale Within a Proven Silver District of Peru VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is providing geological and operational context for its Maria Norte Project by discussing its location within the same regional mineralized corridor as the adjacent Tangana Mining Unit, operated by Silver X Mining Corp., based on publicly available disclosures and technical reporting. The Company believes this context is useful in illustrating the proven endowment of the district, while noting that mineralization on adjacent or nearby properties is not necessarily indicative of mineralization on the Company’s property. District Context and Structural Setting Maria Norte hosts multiple...

Consolidated Lithium Metals Provides Update on Kwyjibo Rare Earth Project

Written by Customer Service on February 5, 2026. Posted in Public Companies.

TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) announces today that it has entered into an amendment effective February 4, 2026 (the “Amendment”) to the previously announced definitive agreement dated November 17, 2025, between the Company and SOQUEM Inc. (“SOQUEM”), a wholly owned subsidiary of Investissement Québec, pursuant to which the Company has acquired an option to earn, subject to the satisfaction of certain conditions, an undivided interest of up to 80% in the Kwyjibo Rare Earth Project (the “Project”), located 125 km northeast of the city of Sept-Îles, in the Côte-Nord region of Québec (the “Transaction”). The purpose of the Amendment is to clarify certain provisions with respect to the mechanism of issuing common shares of the...

Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Written by Customer Service on February 5, 2026. Posted in Public Companies.

PURCHASE, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, has extended the duration of the expanded access program (EAP) for dementia with Lewy bodies (DLB). The program, which was originally expected to provide each participant with twelve months of treatment, will now allow several more months of treatment. “The EAP has been running since June 2025 and is expected to provide us with additional long-term safety data,” stated Anthony O. Caggiano, MD, PhD, Cognition’s chief medical officer. “We’ve received favorable feedback during the program from participants and their care partners about their experience in this program. We implemented a strategy that reduces the amount of...

MACOM Reports Fiscal First Quarter 2026 Financial Results

Written by Customer Service on February 5, 2026. Posted in Public Companies.

LOWELL, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced its financial results for its fiscal first quarter ended January 2, 2026. First Quarter Fiscal Year 2026 GAAP ResultsRevenue was $271.6 million, an increase of 24.5%, compared to $218.1 million in the previous year fiscal first quarter and an increase of 4.0% compared to $261.2 million in the prior fiscal quarter; Gross margin was 55.9%, compared to 53.7% in the previous year fiscal first quarter and 54.5% in the prior fiscal quarter; Income from operations was $43.3 million, or 15.9% of revenue, compared to income from operations of $17.5 million, or 8.0% of revenue, in the previous year fiscal first quarter and income from operations of $39.6 million,...

Sotera Health Appoints Richard Kyle to the Board of Directors

Written by Customer Service on February 5, 2026. Posted in Public Companies.

CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors. Mr. Kyle will serve as a member of the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors. Most recently, Mr. Kyle served as President and Chief Executive Officer of The Timken Company (“Timken”) (NYSE: TKR), a global manufacturer of bearings, transmissions, and industrial motion products, from May 2014 to September 2024. During his tenure as CEO, Mr. Kyle led Timken’s financial transformation and strategic diversification,...

Ero Delivers Record Q4 Production and Strong Year-End Liquidity; Gold Concentrate Sales to Continue Through Mid-2027, Positioning for Next Phase of Step-Change Growth

Written by Customer Service on February 5, 2026. Posted in Public Companies.

(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce record 2025 copper production and provide 2026 guidance and an updated three-year production outlook. HIGHLIGHTS Fourth Quarter and Full Year 2025 ResultsOptimization initiatives across the Company’s operating portfolio in 2025 contributed to record quarterly copper production of 19,706 tonnes and quarterly gold production of 13,837 ounces, representing production improvements of nearly 60% and more than 100% compared to Q1 for copper and gold, respectively.An additional 14,999 ounces of gold in concentrates were sold from the Xavantina Operations during Q4, the result of a year-long value-creation initiative...

Viridian Continues to Define Large-Scale, Near-Surface Mineralization at Kraken

Written by Customer Service on February 5, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) is pleased to report final assay results from the remaining 17 drill holes completed during its 2025 drilling program at the Kraken Main Zone, located in Labrador, Canada.Final assays reported from the remaining 17 drill holes completed during the 2025 program at the Kraken Main Zone Consistent, near-surface sulphide mineralization confirmed over an additional 360 metres of strike length, including tens of metres of mineralization intersected above the primary target horizon. Near-continuous sulphide mineralization defined over ~600 m × ~200 m (5 km EM conductor, supporting a large intrusive-hosted sulphide system“The final assays from our 2025 drilling program reinforce our interpretation of the Kraken...

P10 Expands into Lower-Middle Market Direct Lending with Acquisition of Stellus Capital Management

Written by Customer Service on February 5, 2026. Posted in Mergers And Acquisitions.

Established direct lender with a 20+ year track record will add approximately $3.8 billion in assets under managementLower-middle market focus a natural fit with existing P10 strategies DALLAS, Feb. 05, 2026 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (“P10” or the “Company”), a leading private markets solutions provider, today announced it has entered into a definitive agreement to acquire Stellus Capital Management, LLC (“Stellus”), a U.S. direct lender specializing in senior secured loans in the lower-middle market, for an initial purchase price of $250 million. Stellus will continue to be managed by its current partners who will retain control of its day-to-day operations, including investment decisions and investment committee processes. Based in Houston, TX, Stellus is an established direct lending platform that provides senior-secured...

Orion Achieves Positive Operating Income and Continued Growth in Revenue and Profitability in Q3 2026; Reiterates Increase in FY 2026 Expectation and Establishment of FY 2027 Outlook

Written by Customer Service on February 5, 2026. Posted in Earnings Releases And Operating Results.

MANITOWOC, Wisc., Feb. 05, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today reported results for its fiscal 2026 third quarter (Q3’26) ended December 31, 2025. Orion’s Q3’26 revenue was $21.1M vs. $19.6M in Q3’25, while Q3’26 Gross Profit Percentage was 30.9% vs. 29.4% in Q3’25. The Company achieved positive operating income in Q3’26 and adjusted EBITDA of 3.6% — marking its fifth consecutive quarter of positive adjusted EBITDA — compared to an operating loss of $1.2 million and positive adjusted EBITDA of 0.2% in Q3’25. Additionally, Orion reiterated its January 20 announcement of its increase in the Company’s FY 2026 revenue outlook to a range of between $84 million...

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Written by Customer Service on February 5, 2026. Posted in Earnings Releases And Operating Results.

SOL-1 Phase 3 superiority trial results remain masked to date SOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular plans to submit NDA for AXPAXLI™ in wet AMD based on SOL-1 52 Week data, pending positive results and planned FDA interactions Completed randomization of 631 subjects in SOL-R Phase 3 non-inferiority trial in December 2025; timing of topline results accelerated and now anticipated in 1Q 2027 HELIOS-3 Phase 3 trial in diabetic retinopathy underway Cash balance of $737.1 million as of December 31, 2025, with expected runway into 2028 BEDFORD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today provided recent business highlights and reported financial...

Day: February 5, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals